Literature DB >> 16672388

Molecular epidemiology of Haemophilus influenzae type b causing vaccine failures in the United Kingdom.

Belén Aracil1, Mary Slack, María Pérez-Vázquez, Federico Román, Mary Ramsay, José Campos.   

Abstract

Haemophilus influenzae type b (Hib) was a major cause of pediatric disease in the United Kingdom prior to the introduction of routine Hib immunization in 1992. An unexpected resurgence of cases of vaccine failure was observed with fully vaccinated children from 1999 onward. We investigated whether Hib isolates causing vaccine failures in the United Kingdom could have undergone a change in their population structure to elude the protective effect of Hib vaccine. Molecular epidemiology studies were carried out with 376 isolates from invasive infections (164 vaccine failures and 212 controls). Genetic variability was higher in controls than in vaccine failures. Of the four major clusters obtained, cluster I comprised 92.2% of the total isolates: 156 vaccine failures (95%) and 193 (91%) controls. Cluster IV was specific for vaccine failures but included only four isolates. The increased number of cases of invasive Hib in fully vaccinated children in the United Kingdom was caused by isolates belonging not to a particular or new genotype but to genotypes already circulating in the prevaccination era, before conjugate Hib vaccines were available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672388      PMCID: PMC1479165          DOI: 10.1128/JCM.44.5.1645-1649.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Reemergence of invasive Haemophilus influenzae type b disease in Alaska: Is it because of vaccination with polyribosylribitol phosphate outer membrane protein complex (PRP-OMPC) or failure to vaccinate with PRP-OMPC?

Authors:  J M Dargan; P M Coplan; K M Kaplan; A Nikas
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

2.  Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.

Authors:  R S Daum; C E Zenko; G Z Given; G A Ballanco; H Parikh; K Germino
Journal:  J Infect Dis       Date:  2001-10-15       Impact factor: 5.226

3.  Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing.

Authors:  Emma Meats; Edward J Feil; Suzanna Stringer; Alison J Cody; Richard Goldstein; J Simon Kroll; Tanja Popovic; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign.

Authors:  C L Trotter; M E Ramsay; M P E Slack
Journal:  Commun Dis Public Health       Date:  2003-04

Review 5.  Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses.

Authors:  E Vidor; A Hoffenbach; M A Fletcher
Journal:  Curr Med Res Opin       Date:  2001       Impact factor: 2.580

6.  Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands.

Authors:  Leo M Schouls; Arie van der Ende; Ingrid van de Pol; Corrie Schot; Lodewijk Spanjaard; Paul Vauterin; Dorus Wilderbeek; Sandra Witteveen
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method.

Authors:  Mary E Ramsay; Jodie McVernon; Nick J Andrews; Paul T Heath; Mary P Slack
Journal:  J Infect Dis       Date:  2003-07-31       Impact factor: 5.226

8.  Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b.

Authors:  José Campos; Margarita Hernando; Federico Román; María Pérez-Vázquez; Belén Aracil; Jesús Oteo; Edurne Lázaro; Francisco de Abajo
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

9.  Molecular epidemiology of Haemophilus influenzae type b isolated from children with clinical cases of conjugate vaccine failures.

Authors:  José Campos; Belén Aracil; Federico Román; María Pérez-Vázquez
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

View more
  7 in total

1.  RocA Is an Accessory Protein to the Virulence-Regulating CovRS Two-Component System in Group A Streptococcus.

Authors:  Ira Jain; Eric W Miller; Jessica L Danger; Kathryn J Pflughoeft; Paul Sumby
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

2.  Characterisation of invasive Haemophilus influenzae isolates in Slovenia, 1993-2008.

Authors:  T Kastrin; M Paragi; J Kolman; M Cizman; A Kraigher; M Gubina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-21       Impact factor: 3.267

3.  Regulatory rewiring confers serotype-specific hyper-virulence in the human pathogen group A Streptococcus.

Authors:  Eric W Miller; Jessica L Danger; Anupama B Ramalinga; Nicola Horstmann; Samuel A Shelburne; Paul Sumby
Journal:  Mol Microbiol       Date:  2015-08-14       Impact factor: 3.501

4.  Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.

Authors:  Silvia García-Cobos; José Campos; Edurne Lázaro; Federico Román; Emilia Cercenado; César García-Rey; María Pérez-Vázquez; Jesús Oteo; Francisco de Abajo
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

5.  Natural disruption of two regulatory networks in serotype M3 group A Streptococcus isolates contributes to the virulence factor profile of this hypervirulent serotype.

Authors:  Tram N Cao; Zhuyun Liu; Tran H Cao; Kathryn J Pflughoeft; Jeanette Treviño; Jessica L Danger; Stephen B Beres; James M Musser; Paul Sumby
Journal:  Infect Immun       Date:  2014-02-10       Impact factor: 3.441

6.  Identification and Characterization of Serotype-Specific Variation in Group A Streptococcus Pilus Expression.

Authors:  Gregory Calfee; Jessica L Danger; Ira Jain; Eric W Miller; Poulomee Sarkar; Brian Tjaden; Bernd Kreikemeyer; Paul Sumby
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

7.  Population structure in nontypeable Haemophilus influenzae.

Authors:  Nathan C LaCross; Carl F Marrs; Janet R Gilsdorf
Journal:  Infect Genet Evol       Date:  2012-12-22       Impact factor: 3.342

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.